Oncternal Therapeutics (ONCT) Q2 2023 Earnings

Aug 10Confirmed
Nov 2022
Q4 2022
Q1 2023
Q2 2023
-0.24
-0.21
-0.18
-0.15

Details

Expected EPS
-0.16
Actual EPS
-0.15
Surprise EPS
0.01
Surprise Percent
+6.25%

Description

⁨Oncternal Therapeutics⁩ (⁦ONCT⁩) has reported earnings of ⁦-0.15⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts